
|Articles|March 19, 2008
NovoLog insulin aspart approved for pediatric use
The Food and Drug Administration approved the NovoLog insulin pump in pediatric patients, aged 4 to 18.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement













